EN 中文

CUSTOMER REVIEWS

FDA

“We have a need for the BioPen System to be used for studying variations in cell contractility due to the exposure of certain drugs or combinations of drugs. [The BioPen] is critical for this effort in acquiring large amounts of data. It has two advantages:
1) allows us to save money on expensive drugs because it uses very small amounts;
2) allows us to save money and resources in stem cell differentiation because the same culture of cells can be used for many measurements.”

 

Dr. Joseph Bruton at Karolinska Institutet

“I chose the BioPen System because I can target precise areas of the cell and see how local and global calcium changes in response to different perturbations. The small size of the area means that multiple sites can be examined in a single muscle cell.
The BioPen System has several advantages:
– small footprint on the lab bench,
– small target area, although this can be enlarged quite a bit,
– consumption of expensive antibodies and drugs is minimized compared to perfusion of the whole cell as we used to have to do.”

 

Dr. Niek Welkenhuysen at Chalmers University

“The major advantages of the BioPen system for us is that it is rather smooth to set up an experiment, both hardware and software are easy to handle and it allowed us to rapidly switch between flows. Aside from this, we highly appreciated the support received from the people from Fluicell before and after we bought the BioPen system.”

 

Associate Prof. Kent Jadermark at Karolinska Institutet

“We have tested the BioPen in different applications here at Karolinska Institutet and in collaboration with a research group at Göteborg University. I consider the BioPen very valuable for applying compounds or drugs to single cells in culture as well as to specific cell layers in brain slices”.